BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34044136)

  • 1. Live birth rates in different subgroups of poor ovarian responders according to Bologna and POSEIDON group classification criteria.
    Mashayekhi M; Barabi F; Arabipoor A; Zolfaghari Z
    J Gynecol Obstet Hum Reprod; 2021 Nov; 50(9):102169. PubMed ID: 34044136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
    Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live birth rate per fresh embryo transfer and cumulative live birth rate in patients with PCOS under the POSEIDON classification: a retrospective study.
    Jiang L; Sun Y; Pan P; Li L; Yang D; Huang J; Li Y
    Front Endocrinol (Lausanne); 2024; 15():1348771. PubMed ID: 38863934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative live birth rates in low-prognosis women.
    Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; van Golde RJT; Hoek A; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Torrance HL; Broekmans FJM;
    Hum Reprod; 2019 Jun; 34(6):1030-1041. PubMed ID: 31125412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bologna vs. POSEIDON criteria as predictors of the likelihood of obtaining at least one euploid embryo in poor ovarian response: an analysis of 6,889 cycles.
    Reig A; Garcia-Velasco JA; Seli E
    Fertil Steril; 2023 Sep; 120(3 Pt 2):605-614. PubMed ID: 37187313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors for Live Birth in Fresh
    Li F; Ye T; Kong H; Li J; Hu L; Jin H; Guo Y; Li G
    Front Endocrinol (Lausanne); 2021; 12():630832. PubMed ID: 33967954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live birth rates of low prognosis patients according to POSEIDON criteria; A retrospective cohort study.
    Seven B; Gulerman C; Ozgu-Erdinc AS; Yilmaz N; Engin-Ustun Y
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101817. PubMed ID: 32428781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.
    Grisendi V; Mastellari E; La Marca A
    Front Endocrinol (Lausanne); 2019; 10():281. PubMed ID: 31139145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
    Zhang S; Yin Y; Li Q; Zhang C
    Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal number of embryos to transfer for POSEIDON group 1 and group 2? A retrospective study.
    Liu R; Zhang Q; Geng L; He H; Xu C; Feng J; Song M; Cao Y; Wang T; Xia X
    J Ovarian Res; 2024 May; 17(1):117. PubMed ID: 38822354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria.
    Polyzos NP; Blockeel C; Verpoest W; De Vos M; Stoop D; Vloeberghs V; Camus M; Devroey P; Tournaye H
    Hum Reprod; 2012 Dec; 27(12):3481-6. PubMed ID: 22940767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognosis of IVF in Poor Responders Depending on the Bologna Criteria: A Large Sample Retrospective Study from China.
    Yang S; Chen X; Zhen X; Wang H; Ma C; Li R; Liu P; Qiao J
    Biomed Res Int; 2015; 2015():296173. PubMed ID: 26844227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
    Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
    Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis.
    Yang R; Zhang C; Chen L; Wang Y; Li R; Liu P; Qiao J
    Reprod Biomed Online; 2020 Nov; 41(5):834-844. PubMed ID: 32978073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.
    JOINT SOGC-CFAS
    Int J Gynaecol Obstet; 2008 Aug; 102(2):203-16. PubMed ID: 18773532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
    Roque M; Haahr T; Geber S; Esteves SC; Humaidan P
    Hum Reprod Update; 2019 Jan; 25(1):2-14. PubMed ID: 30388233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.
    Liu X; Xu J; Bi L; Liu P; Jiao X
    Front Endocrinol (Lausanne); 2021; 12():790160. PubMed ID: 34925245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.
    Hu X; Liu Y; Zhang X; Lee P; Wen Y; Ding C; Zhou C; Xu Y
    Front Endocrinol (Lausanne); 2021; 12():705733. PubMed ID: 34484119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Serum LH Levels During Ovarian Stimulation With GnRH Antagonist Protocol Decrease the Live Birth Rate After Fresh Embryo Transfers but Have No Impact in Freeze-All Cycles.
    Luo Y; Liu S; Su H; Hua L; Ren H; Liu M; Wan Y; Li H; Li Y
    Front Endocrinol (Lausanne); 2021; 12():640047. PubMed ID: 33967956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.